Therapeutic potential of klotho–FGF23 fusion polypeptides: WO2009095372

Bibliography

• Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000;277:494-8
   PubMed Web of Science ®Google Scholar
• ADHR_Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR Consortium. Nat Genet 2000;26:345-8
   Google Scholar
• Shimada T, Mizutani S, Muto T, Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001;98:6500-5
   PubMed Web of Science ®Google Scholar
• Goetz R, Nakada Y, Hu MC, Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci USA 2010;107:407-12
   PubMed Web of Science ®Google Scholar
• Medici D, Razzaque MS, Deluca S, FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 2008;182:459-65
   PubMed Web of Science ®Google Scholar
• Jonsson KB, Zahradnik R, Larsson T, Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656-63
   PubMed Web of Science ®Google Scholar
• Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 2005;14:385-90
   PubMed Web of Science ®Google Scholar
• Fliser D, Kollerits B, Neyer U, Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007;18:2600-8
   PubMed Web of Science ®Google Scholar
• Koh N, Fujimori T, Nishiguchi S, Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 2001;280:1015-20
   PubMed Web of Science ®Google Scholar
• Chen CD, Podvin S, Gillespie E, Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 2007;104:19796-801
   PubMed Web of Science ®Google Scholar
• Kuro-o M, Matsumura Y, Aizawa H, Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51
   PubMed Web of Science ®Google Scholar
• Nakatani T, Bara S, Ohnishi M, In vivo genetic evidence of klotho-dependent functions of FGF23 in regulation of systemic phosphate homeostasis. Faseb J 2009;23:433-41
   PubMedGoogle Scholar
• Razzaque MS, Lanske B. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 2006;12:298-305
   PubMed Web of Science ®Google Scholar
• Ohnishi M, Nakatani T, Lanske B, Razzaque MS. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 2009;75:1166-72
   Google Scholar
• Razzaque MS, Sitara D, Taguchi T, Premature ageing-like phenotype in fibroblast growth factor 23 null mice is a vitamin-D mediated process. FASEB J 2006;20:720-2
   PubMed Web of Science ®Google Scholar
• Razzaque MS. The FGF23 Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 2009;5:611-9
   PubMed Web of Science ®Google Scholar
• Razzaque MS. FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol 2009;296:F470-6
   Google Scholar
• Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 2005;16:107-37
   PubMed Web of Science ®Google Scholar
• Kurosu H, Ogawa Y, Miyoshi M, Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006;281:6120-3
   PubMed Web of Science ®Google Scholar
• Urakawa I, Yamazaki Y, Shimada T, Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006;444:770-4
   PubMed Web of Science ®Google Scholar
• Gattineni J, Bates C, Twombley K, FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 2009: doi: 10.1152/ajprenal.90742.2008
   Google Scholar
• Liu S, Vierthaler L, Tang W, FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 2008;19:2342-50
   PubMed Web of Science ®Google Scholar
• Goetz R, Beenken A, Ibrahimi OA, Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 2007;27:3417-28
   PubMed Web of Science ®Google Scholar
• Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 2006;15:437-41
   PubMed Web of Science ®Google Scholar
• Nakatani T, Ohnishi M, Razzaque MS. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Faseb J 2009;23:3702-11
   Google Scholar
• Razzaque MS, Lanske B. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol 2007;194:1-10
   PubMed Web of Science ®Google Scholar
• Razzaque MS. Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant 2009;24:4-7
   PubMedGoogle Scholar
• Shimada T, Urakawa I, Isakova T, Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 2009. doi: 10.1210/jc.2009-1603
   Google Scholar
• Lafage-Proust MH. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Kidney Int 2010;77:390-2
   Google Scholar
• Ohnishi M, Nakatani T, Lanske B, Razzaque MS. In vivo genetic evidence for suppressing vascular and soft tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin-D levels. Circ Cardiovasc Genet 2009;2:583-90
   Google Scholar
• Lanske B, Razzaque MS. Premature aging in klotho mutant mice: cause or consequence? Ageing Res Rev 2007;6:73-9
   Google Scholar
• Lanske B, Razzaque MS. Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr Opin Nephrol Hypertens 2007;16:311-8
   Google Scholar
• Razzaque MS. Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism? Nat Clin Pract Endocrinol Metab 2007;3:788-9
   Google Scholar